$XELB
XCel Brands, Inc.

2024 Q4 Form 10-Q Financial Statement

#000155837024016432 Filed on December 20, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $1.912M
YoY Change -27.49%
Cost Of Revenue $407.0K
YoY Change 80.89%
Gross Profit $1.505M
YoY Change -37.6%
Gross Profit Margin 78.71%
Selling, General & Admin $1.618M
YoY Change -53.53%
% of Gross Profit 107.51%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $910.0K
YoY Change -45.74%
% of Gross Profit 60.47%
Operating Expenses $1.618M
YoY Change -53.53%
Operating Profit -$9.078M
YoY Change 68.02%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$9.220M
YoY Change 70.65%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$9.213M
YoY Change 79.1%
Net Earnings / Revenue -481.85%
Basic Earnings Per Share -$0.39
Diluted Earnings Per Share -$0.39
COMMON SHARES
Basic Shares Outstanding 23.64M 23.51M
Diluted Shares Outstanding 23.52M

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $200.0K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $2.908M
Other Receivables
Total Short-Term Assets $3.525M
YoY Change -57.95%
LONG-TERM ASSETS
Property, Plant & Equipment $202.0K
YoY Change -74.07%
Goodwill
YoY Change
Intangibles $35.64M
YoY Change -17.22%
Long-Term Investments $9.796M
YoY Change -44.5%
Other Assets $911.0K
YoY Change 1114.67%
Total Long-Term Assets $50.47M
YoY Change -25.08%
TOTAL ASSETS
Total Short-Term Assets $3.525M
Total Long-Term Assets $50.47M
Total Assets $54.00M
YoY Change -28.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due $1.000M
YoY Change
Total Short-Term Liabilities $6.783M
YoY Change 1.91%
LONG-TERM LIABILITIES
Long-Term Debt $3.297M
YoY Change
Other Long-Term Liabilities $431.0K
YoY Change -96.88%
Total Long-Term Liabilities $12.25M
YoY Change -11.14%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.783M
Total Long-Term Liabilities $12.25M
Total Liabilities $19.03M
YoY Change -6.89%
SHAREHOLDERS EQUITY
Retained Earnings -$69.20M
YoY Change 46.92%
Common Stock $24.00K
YoY Change 20.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $36.92M
YoY Change
Total Liabilities & Shareholders Equity $54.00M
YoY Change -28.71%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$9.213M
YoY Change 79.1%
Depreciation, Depletion And Amortization $910.0K
YoY Change -45.74%
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001083220
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23581290
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19795053
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37527
dei Entity Registrant Name
EntityRegistrantName
XCEL BRANDS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
76-0307819
dei Entity Address Address Line1
EntityAddressAddressLine1
550 Seventh Avenue, 11th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10018
dei City Area Code
CityAreaCode
347
dei Local Phone Number
LocalPhoneNumber
727-2474
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
XELB
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
23639973
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
242000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2998000
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
30000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
75000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2908000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3454000
CY2023Q4 us-gaap Inventory Net
InventoryNet
453000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
375000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
398000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
3525000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
7303000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
202000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
634000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3923000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4453000
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
35642000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
41520000
CY2024Q3 us-gaap Equity Method Investments
EquityMethodInvestments
9796000
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
17735000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
911000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
15000
CY2024Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
50474000
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
64357000
CY2024Q3 us-gaap Assets
Assets
53999000
CY2023Q4 us-gaap Assets
Assets
71660000
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2602000
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2236000
CY2024Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1376000
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
889000
CY2024Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
372000
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
372000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1433000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1258000
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
1000000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
750000
CY2023Q4 xelb Current Portion Of Contingent Obligations
CurrentPortionOfContingentObligations
964000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
6783000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6469000
CY2024Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
2889000
CY2023Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3556000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5633000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4021000
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3297000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3971000
CY2023Q4 us-gaap Asset Acquisition Contingent Consideration Liability Noncurrent
AssetAcquisitionContingentConsiderationLiabilityNoncurrent
5432000
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
431000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
40000
CY2024Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
12250000
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
17020000
CY2024Q3 us-gaap Liabilities
Liabilities
19033000
CY2023Q4 us-gaap Liabilities
Liabilities
23489000
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23581290
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19795053
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
24000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
20000
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
106056000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
103861000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-69161000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-53849000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
36919000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
50032000
CY2024Q3 us-gaap Minority Interest
MinorityInterest
-1953000
CY2023Q4 us-gaap Minority Interest
MinorityInterest
-1861000
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
34966000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
48171000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
53999000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
71660000
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1912000
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2637000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
7050000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
15468000
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
407000
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
225000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
445000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6718000
CY2024Q3 us-gaap Gross Profit
GrossProfit
1505000
CY2023Q3 us-gaap Gross Profit
GrossProfit
2412000
us-gaap Gross Profit
GrossProfit
6605000
us-gaap Gross Profit
GrossProfit
8750000
CY2024Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
1208000
CY2023Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
2141000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
4771000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
7847000
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1618000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3482000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5137000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9918000
CY2024Q3 us-gaap Costs And Expenses
CostsAndExpenses
2826000
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
5623000
us-gaap Costs And Expenses
CostsAndExpenses
9908000
us-gaap Costs And Expenses
CostsAndExpenses
17765000
CY2024Q3 xelb Operating Income Loss Before Other Expense
OperatingIncomeLossBeforeOtherExpense
-1321000
CY2023Q3 xelb Operating Income Loss Before Other Expense
OperatingIncomeLossBeforeOtherExpense
-3211000
xelb Operating Income Loss Before Other Expense
OperatingIncomeLossBeforeOtherExpense
-3303000
xelb Operating Income Loss Before Other Expense
OperatingIncomeLossBeforeOtherExpense
-9015000
CY2024Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
910000
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1677000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4044000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5260000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
3483000
CY2024Q3 xelb Loss From Equity Method Investments
LossFromEquityMethodInvestments
593000
CY2023Q3 xelb Loss From Equity Method Investments
LossFromEquityMethodInvestments
515000
xelb Loss From Equity Method Investments
LossFromEquityMethodInvestments
1683000
xelb Loss From Equity Method Investments
LossFromEquityMethodInvestments
1545000
CY2024Q3 xelb Asset Acquisition Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability
AssetAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability
6254000
xelb Asset Acquisition Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability
AssetAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability
6254000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
3801000
xelb Gain Loss On Sale Of Limited Partner Ownership Interest
GainLossOnSaleOfLimitedPartnerOwnershipInterest
351000
us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
445000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9078000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5403000
us-gaap Operating Income Loss
OperatingIncomeLoss
-14966000
us-gaap Operating Income Loss
OperatingIncomeLoss
-15024000
CY2024Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-142000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-438000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-18000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9220000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5403000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15404000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15042000
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-9220000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-5403000
us-gaap Profit Loss
ProfitLoss
-15404000
us-gaap Profit Loss
ProfitLoss
-15042000
CY2024Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-7000
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-259000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-92000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-787000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-9213000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-5144000
us-gaap Net Income Loss
NetIncomeLoss
-15312000
us-gaap Net Income Loss
NetIncomeLoss
-14255000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.39
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.26
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.68
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.72
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.39
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.26
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.68
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.72
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23522453
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19749317
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22466737
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19683525
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23522453
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19749317
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22466737
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19683525
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
70139000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
51000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-5938000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
64258000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
27000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-3701000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
60623000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
36000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
16000
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
27000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-5403000
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
55309000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
48171000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
36000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
10000
CY2024Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
1902000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-6345000
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
43872000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
32000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
10000
CY2024Q2 us-gaap Profit Loss
ProfitLoss
161000
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
44075000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
37000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
9000
CY2024Q3 xelb Stock Issued During Period Pro Rata Of Base Salary Value
StockIssuedDuringPeriodProRataOfBaseSalaryValue
55000
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-9220000
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
34966000
us-gaap Profit Loss
ProfitLoss
-15404000
us-gaap Profit Loss
ProfitLoss
-15042000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4044000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5260000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
3483000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
100000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
76000
us-gaap Share Based Compensation
ShareBasedCompensation
296000
us-gaap Share Based Compensation
ShareBasedCompensation
184000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-45000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
20000
us-gaap Restructuring Costs
RestructuringCosts
756000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1683000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1545000
xelb Asset Acquisition Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability
AssetAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability
6254000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
3801000
xelb Gain Loss On Sale Of Limited Partner Ownership Interest
GainLossOnSaleOfLimitedPartnerOwnershipInterest
351000
us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
445000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-591000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
415000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-453000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1848000
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
134000
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-920000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-180000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
4676000
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-304000
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-1395000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-710000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-471000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
391000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3307000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2810000
xelb Net Proceeds From Sale Of Majority Interest In Investing Activity
NetProceedsFromSaleOfMajorityInterestInInvestingActivity
451000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
112000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
87000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-112000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
364000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
27000
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
1902000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
500000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1402000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
27000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2017000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2419000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2998000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4608000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
981000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2189000
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
242000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2189000
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
739000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
981000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2189000
xelb Operating Lease Right Of Use Asset Non Cash
OperatingLeaseRightOfUseAssetNonCash
2596000
xelb Operating Lease Liability Non Cash
OperatingLeaseLiabilityNonCash
2596000
us-gaap Interest Paid Net
InterestPaidNet
344000
us-gaap Income Taxes Paid
IncomeTaxesPaid
16000
us-gaap Net Income Loss
NetIncomeLoss
-15300000
us-gaap Other Noncash Expense
OtherNoncashExpense
15800000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-69200000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3300000
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2600000
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
200000
CY2024Q3 xelb Working Capital Net
WorkingCapitalNet
-400000
CY2024Q4 xelb Increase Decrease In Working Capital
IncreaseDecreaseInWorkingCapital
4500000
CY2023 xelb Reduction In Operating Expenses Over Next Year
ReductionInOperatingExpensesOverNextYear
15000000
CY2024Q3 xelb Amount Of Contractual Obligations Relieved Due To Divestiture Transaction
AmountOfContractualObligationsRelievedDueToDivestitureTransaction
1000000
CY2024Q3 xelb Amount Of Potential Future Contingent Obligations Relieved Due To Divestiture Transaction
AmountOfPotentialFutureContingentObligationsRelievedDueToDivestitureTransaction
11000000
xelb Operating Expense Run Rate
OperatingExpenseRunRate
11000000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2000000
CY2024Q3 us-gaap Asset Acquisition Contingent Consideration Liability Current
AssetAcquisitionContingentConsiderationLiabilityCurrent
6300000
CY2024Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
59009000
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
23367000
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
35642000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
69309000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
27789000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
41520000
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
890000
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1530000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3950000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4600000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
884000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
3531000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
3506000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
3503000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
3503000
CY2024Q3 xelb Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
20715000
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
35642000
CY2024Q3 us-gaap Sublease Income
SubleaseIncome
200000
us-gaap Sublease Income
SubleaseIncome
500000
CY2023Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
400000
CY2024Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
400000
us-gaap Operating Lease Payments
OperatingLeasePayments
1200000
us-gaap Operating Lease Payments
OperatingLeasePayments
1200000
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y9M25D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0778
us-gaap Lease Expiration Date1
LeaseExpirationDate1
2027-10-30
CY2024Q3 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.0960
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
388000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1926000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2060000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1841000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
570000
CY2024Q3 xelb Lessee Operating Lease Liability Payments Due Year Five And After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive
2005000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
8790000
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1724000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
7066000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1433000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5633000
CY2024Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
4500000
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
5000000
CY2024Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
203000
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
279000
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
4297000
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
4721000
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
1000000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
750000
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3297000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3971000
CY2024Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
130000
us-gaap Interest Expense Debt
InterestExpenseDebt
420000
us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.116
CY2024Q3 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.116
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
150000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
320000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
170000
CY2024Q3 xelb Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Salary Paid In Stock
ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfSalaryPaidInStock
0.40
CY2024Q3 xelb Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Salary Divided By Share Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfSalaryDividedBySharePrice
0.40
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2900118
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-9213000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-5144000
us-gaap Net Income Loss
NetIncomeLoss
-15312000
us-gaap Net Income Loss
NetIncomeLoss
-14255000
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23522453
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19749317
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22466737
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19683525
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23522453
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19749317
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22466737
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19683525
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.39
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.26
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.68
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.72
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.39
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.26
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.68
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.72
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5907937
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6260235
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5907937
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6260235
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2024Q3 us-gaap Payments For Royalties
PaymentsForRoyalties
137500
us-gaap Payments For Royalties
PaymentsForRoyalties
237500
CY2024Q3 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
137500

Files In Submission

Name View Source Status
0001558370-24-016432-index-headers.html Edgar Link pending
0001558370-24-016432-index.html Edgar Link pending
0001558370-24-016432.txt Edgar Link pending
0001558370-24-016432-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
xelb-20240930.xsd Edgar Link pending
xelb-20240930x10q.htm Edgar Link pending
xelb-20240930xex31d1.htm Edgar Link pending
xelb-20240930xex31d2.htm Edgar Link pending
xelb-20240930xex32d1.htm Edgar Link pending
xelb-20240930xex32d2.htm Edgar Link pending
xelb-20240930_cal.xml Edgar Link unprocessable
xelb-20240930_def.xml Edgar Link unprocessable
xelb-20240930_lab.xml Edgar Link unprocessable
xelb-20240930_pre.xml Edgar Link unprocessable
xelb-20240930x10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable